Cargando…

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes

BACKGROUND: To examine the effects of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on visceral fat adiposity, appetite, food preference, and biomarkers of cardiovascular system in Japanese patients with type 2 diabetes. METHODS: The study subjects were 20 inpatients with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Kana, Maeda, Norikazu, Kashine, Susumu, Fujishima, Yuya, Kozawa, Junji, Hiuge-Shimizu, Aki, Okita, Kohei, Imagawa, Akihisa, Funahashi, Tohru, Shimomura, Iichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260096/ https://www.ncbi.nlm.nih.gov/pubmed/22132774 http://dx.doi.org/10.1186/1475-2840-10-109

Ejemplares similares

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
por: Fujishima, Yuya, et al.
Publicado: (2012)

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
por: Kozawa, Junji, et al.
Publicado: (2012)

A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells
por: Yamaoka, Masaya, et al.
Publicado: (2012)

Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation
por: Fukuda, Shiro, et al.
Publicado: (2015)

Characteristics of sleep–wake cycle and sleep duration in Japanese type 2 diabetes patients with visceral fat accumulation
por: Fukuda, Shiro, et al.
Publicado: (2017)

Usefulness of the insulin tolerance test in patients with type 2 diabetes receiving insulin therapy
por: Okita, Kohei, et al.
Publicado: (2013)

Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity
por: Nagao, Hirofumi, et al.
Publicado: (2013)

Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance
por: Kozawa, Junji, et al.
Publicado: (2012)

Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
por: Inoue, Kana, et al.
Publicado: (2014)

Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients
por: Kozawa, Junji, et al.
Publicado: (2011)

Weight reduction is associated with improvement of glycemic control in Japanese men, whose hemoglobin A1C is 5.6–6.4%, with visceral fat accumulation, but not without visceral fat accumulation
por: Okauchi, Yukiyoshi, et al.
Publicado: (2013)

Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency
por: Fujita, Yukari, et al.
Publicado: (2013)

Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient
por: D Hayashi, Reiko, et al.
Publicado: (2017)

High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome
por: Hirata, Ayumu, et al.
Publicado: (2012)

Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study
por: Okauchi, Yukiyoshi, et al.
Publicado: (2011)

A Japanese patient with a 2p25.3 terminal deletion presented with early‐onset obesity, intellectual disability and diabetes mellitus: A case report
por: Sakaue, Taka‐aki, et al.
Publicado: (2021)

Predictors of deterioration of glucose tolerance and effects of lifestyle intervention aimed at reducing visceral fat in normal glucose tolerance subjects with abdominal obesity
por: Akita, Etsuko F, et al.
Publicado: (2010)

Suppression Failure of Cortisol Secretion by Dexamethasone May Occur in Glucagon-like Peptide-1 Receptor Agonist-treated Patients with Diabetic Autonomic Neuropathy
por: Nagai, Yasuki, et al.
Publicado: (2018)

Diabetes due to Mitochondrial Adipopathy
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity
por: Inoue, Kana, et al.
Publicado: (2013)

Ultrastructural Localization of Adiponectin protein in Vasculature of Normal and Atherosclerotic mice
por: Mori, Takuya, et al.
Publicado: (2014)

Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspective
por: Kishida, Ken, et al.
Publicado: (2011)

Complete loss of insulin secretion capacity in type 1A diabetes patients during long‐term follow up
por: Uno, Sae, et al.
Publicado: (2017)

Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects
por: Obata, Yoshinari, et al.
Publicado: (2016)

Pseudohypoglycemia or hyperglycemia caused by interference with self‐monitoring blood glucose measurements in anticancer ascorbic acid therapy
por: Kimura, Takekazu, et al.
Publicado: (2013)

Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation
por: Murai, Jun, et al.
Publicado: (2018)

Insulin‐secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non‐obese Japanese patients
por: Iwahashi, Hiromi, et al.
Publicado: (2012)

A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus- a randomized controlled trial START-J study
por: Hibuse, Toshiyuki, et al.
Publicado: (2014)

Hyperinsulinemia and Insulin Receptor Gene Mutation in Nonobese Healthy Subjects in Japan
por: Fujita, Shingo, et al.
Publicado: (2017)

Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction
por: Natsukawa, Tomoaki, et al.
Publicado: (2017)

Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade
por: Kawada-Horitani, Emi, et al.
Publicado: (2022)

Extent of weight reduction necessary for minimization of diabetes risk in Japanese men with visceral fat accumulation and glycated hemoglobin of 5.6–6.4%
por: Iwahashi, Hiromi, et al.
Publicado: (2015)

Case of a novel PAX6 mutation with aniridia and insulin‐dependent diabetes mellitus
por: Motoda, Saori, et al.
Publicado: (2018)

Human pancreatic α‐ to β‐cell area ratio increases after type 2 diabetes onset
por: Fujita, Yukari, et al.
Publicado: (2018)

Ectopic Fat Accumulation in Pancreas and Heart
por: Kozawa, Junji, et al.
Publicado: (2021)

Soluble T-cadherin promotes pancreatic β-cell proliferation by upregulating Notch signaling
por: Okita, Tomonori, et al.
Publicado: (2022)

ER stress decreases exosome production through adiponectin/T-cadherin-dependent and -independent pathways
por: Fukuoka, Keita, et al.
Publicado: (2023)

Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross‐sectional study
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

An Impaired Awareness of Hypoglycemia Improved After Vitamin B(12) Treatment in a Type 1 Diabetic Patient
por: Fujita, Shingo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t6kqisit2gffh64e2r6g4bd70a